Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 1,884Cancer Immunotherapy and BiomarkersT-cell and B-cell ImmunologyImmunotherapy and Immune Responses

The DOI matches its Crossref record; 144 of the 145 references it cites were found in a registry or an index.

Tertiary lymphoid structures in the era of cancer immunotherapy

Open access
Sautès-Fridman, Catherine, Petitprez, Florent, Calderaro, Julien, Fridman, Wolf Herman·2019·Nature reviews. Cancer

Abstract

Tertiary lymphoid structures (TLSs) are ectopic lymphoid organs that develop in non-lymphoid tissues at sites of chronic inflammation including tumours. Key common characteristics between secondary lymphoid organogenesis and TLS neogenesis have been identified. TLSs exist under different maturation states in tumours, culminating in germinal centre formation. The mechanisms that underlie the role of TLSs in the adaptive antitumour immune response are being deciphered. The description of the correlation between TLS presence and clinical benefit in patients with cancer, suggesting that TLSs could be a prognostic and predictive factor, has drawn strong interest into investigating the role of TLSs in tumours. A current major challenge is to exploit TLSs to promote lymphocyte infiltration, activation by tumour antigens and differentiation to increase the antitumour immune response. Several approaches are being developed using chemokines, cytokines, antibodies, antigen-presenting cells or synthetic scaffolds to induce TLS formation. Strategies aiming to induce TLS neogenesis in immune-low tumours and in immune-high tumours, in this case, in combination with therapeutic agents dampening the inflammatory environment and/or with immune checkpoint inhibitors, represent promising avenues for cancer treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41568-019-0144-6

Cites

144 of 144 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 145 references

Cited by

See all 1,884

Metadata

Authors
Sautès-Fridman, C., Petitprez, F., Calderaro, J., & Fridman, W. H.
Affiliations
Inserm (FR)
Venue
Nature reviews. Cancer
Published
2019-05-15
Volume
19
Issue
6
Pages
307-325
ISSN
  • 1474-175X (ISSN-L)
  • 1474-1768
OpenAlex
W2945057866
Cited by
1,884
References
145
Citations by year
2026: 303 · 2025: 353 · 2024: 369 · 2023: 245 · 2022: 237 · 2021: 240 · 2020: 126 · 2019: 9
FWCI
14.63
Type
journal article
Language
en
Licence
Locations
  • Nature reviews. Cancer (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
Funders
  • Association pour la Recherche sur le Cancer
  • Institut National de la Santé et de la Recherche Médicale
  • Institut National Du Cancer (C1608DS)
  • Sorbonne Université
  • Labex Immuno-Oncology
  • Institute of Cancer Research (C1608DS)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
tertiary lymphoid structures, germinal center, antitumor immunity, cancer immunotherapy, immune checkpoint inhibitors, chemokines, cytokines, antigen-presenting cells, synthetic scaffolds, tumor immunogenicity, prognostic factors, chronic inflammation
MeSH terms
Tertiary Lymphoid Structures, Humans, Immunotherapy, Inflammation, Neoplasms, Prognosis, Gene Expression Regulation, Neoplastic, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tertiary lymphoid structures in the era of cancer immunotherapy. https://app.cochat.ai/papers/10.1038/s41568-019-0144-6
The paper
Sautès-Fridman, C., Petitprez, F., Calderaro, J., & Fridman, W. H. (2019). Tertiary lymphoid structures in the era of cancer immunotherapy. Nature reviews. Cancer. https://doi.org/10.1038/s41568-019-0144-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.